Catalio Capital Management LP Takes $3.32 Million Position in Heartflow, Inc. $HTFL

Catalio Capital Management LP bought a new stake in Heartflow, Inc. (NASDAQ:HTFL) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 113,857 shares of the company’s stock, valued at approximately $3,319,000. Catalio Capital Management LP owned about 0.13% of Heartflow at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Caitong International Asset Management Co. Ltd acquired a new position in shares of Heartflow in the fourth quarter valued at approximately $27,000. Russell Investments Group Ltd. acquired a new position in shares of Heartflow in the fourth quarter valued at approximately $45,000. Legal & General Group Plc acquired a new position in shares of Heartflow in the third quarter valued at approximately $59,000. Strs Ohio bought a new stake in shares of Heartflow in the fourth quarter valued at approximately $99,000. Finally, Police & Firemen s Retirement System of New Jersey bought a new stake in shares of Heartflow in the fourth quarter valued at approximately $131,000.

Insider Buying and Selling at Heartflow

In other Heartflow news, CEO John C.M. Farquhar sold 22,562 shares of the firm’s stock in a transaction on Wednesday, June 10th. The stock was sold at an average price of $28.50, for a total value of $643,017.00. Following the sale, the chief executive officer owned 496,835 shares of the company’s stock, valued at approximately $14,159,797.50. This trade represents a 4.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Bain Capital Life Sciences Inv sold 948,757 shares of the firm’s stock in a transaction on Thursday, April 30th. The shares were sold at an average price of $29.23, for a total value of $27,732,167.11. Following the completion of the sale, the insider directly owned 8,448,158 shares in the company, valued at approximately $246,939,658.34. This represents a 10.10% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 2,141,438 shares of company stock valued at $62,651,098. 7.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on HTFL shares. William Blair started coverage on Heartflow in a research note on Monday, May 4th. They issued an “outperform” rating for the company. JPMorgan Chase & Co. cut their price target on Heartflow from $40.00 to $35.00 and set an “overweight” rating for the company in a research note on Thursday, March 19th. Piper Sandler reiterated an “overweight” rating on shares of Heartflow in a research note on Thursday, June 11th. Wells Fargo & Company boosted their price target on Heartflow from $35.00 to $37.00 and gave the company an “overweight” rating in a research note on Friday, May 15th. Finally, Canaccord Genuity Group cut their price target on Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a research note on Friday, May 15th. Six equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $37.00.

Heartflow Stock Performance

Shares of HTFL stock opened at $32.84 on Thursday. The stock’s fifty day moving average price is $29.74 and its two-hundred day moving average price is $28.34. The company has a market cap of $2.83 billion and a PE ratio of -10.56. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $41.22.

Heartflow (NASDAQ:HTFL) last issued its earnings results on Thursday, May 14th. The company reported ($0.16) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.24) by $0.08. The business had revenue of $52.59 million during the quarter. The business’s quarterly revenue was up 41.3% on a year-over-year basis. On average, equities analysts predict that Heartflow, Inc. will post -0.82 EPS for the current fiscal year.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.